Search Results for: Neuralstem

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope

NSRichard08-headshot

A new right-to-try company called Beacon of Hope is stirring some intense discussion. State and federal right-to-try laws could potentially change the fabric of how many investigational studies are conducted. That may happen through firms like Beacon of Hope. However, we don’t know much about the firm. I’m hoping to help change that. Today’s post …

Richard Garr Q&A on his new Right-To-Try firm Beacon of Hope Read More »

Stem Cell Person of the Year 2016: Patient Advocate Ted Harada

Stem-cell-ethics-meeting-e1479769073498

Patient advocate Ted Harada is the recipient of this year’s Stem Cell Person of the Year Award. Congrats also to the runner-up, HD patient advocate Judy Roberson. The three of us together are pictured at left. You can read about the 20 nominees here and see the vote results that picked the 10 finalists here. …

Stem Cell Person of the Year 2016: Patient Advocate Ted Harada Read More »

Tribute to Ted Harada, pioneering stem cell trial participant and ALS advocate

Harada-Family-e1479769086296

It takes a great deal of courage to participate in a clinical trial, patients who make that choice are heroes in my book and one such hero with stem cells was Ted Harada who had ALS. Sadly, Ted passed away from a brain tumor called glioblastoma last month. When enrolling in a trial, you just never …

Tribute to Ted Harada, pioneering stem cell trial participant and ALS advocate Read More »

End of line for StemCells Inc., pioneering & controversial stem cell biotech

stemcellsinc-logo

A sad, but not surprising day for the stem cell field as the biotech StemCells, Inc. announced that it is winding down its operations after terminating its spinal cord injury trial called the Pathway Study. The data generated so far did not justify continuing the trial. StemCells, Inc. (stock symbol STEM) has struggled financially for …

End of line for StemCells Inc., pioneering & controversial stem cell biotech Read More »

Tale of 7 stem cell biotech stock woes

Ocata

To get from point A of a stem cell discovery to point B of a patient actually receiving a treatment based on that discovery is a long and non-linear road, which requires biotech company research. Stem cell biotech companies including publicly traded companies are an integral part of the field making that journey. How those …

Tale of 7 stem cell biotech stock woes Read More »

Meeting review of unique stem cell ethics symposium @UCDAVIS

Stem-cell-ethics-meeting-e1479769073498

On Thursday here at UC Davis School of Medicine we held our second annual Stem Cell Ethics Symposium. The symposium was organized by Drs. Mark Yarborough and Nanette Joyce as well as me. In this post I report on key take homes from the meeting and summarize the specific talks. As far as I know, this is one of the few …

Meeting review of unique stem cell ethics symposium @UCDAVIS Read More »

Stem Cell Person of the Year Award 2014 Voting: Who Will Be Finalists?

turner-leigh

With one week left to vote to pick the top 12 finalists for the Stem Cell Person of the Year 2014 Award, we have more than 2,800 votes in so far. From the top 12 vote-getters, I will choose the winner. This is the third year of this award. I self-fund this award out of …

Stem Cell Person of the Year Award 2014 Voting: Who Will Be Finalists? Read More »